Financial results - PHARMALINK SRL

Financial Summary - Pharmalink Srl
Unique identification code: 31646819
Registration number: J2013006240406
Nace: 7020
Sales - Ron
2.110.322
Net Profit - Ron
416.635
Employees
15
Open Account
Company Pharmalink Srl with Fiscal Code 31646819 recorded a turnover of 2024 of 2.110.322, with a net profit of 416.635 and having an average number of employees of 15. The company operates in the field of Activităţi de consultanţă în afaceri și management having the NACE code 7020.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmalink Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 610.223 826.461 1.326.495 1.501.541 1.963.575 1.772.909 1.645.462 2.449.378 2.078.376 2.110.322
Total Income - EUR 615.304 829.896 1.384.862 1.533.997 2.069.460 1.806.901 1.653.629 2.457.050 2.086.108 2.137.276
Total Expenses - EUR 600.372 780.623 1.089.404 1.175.739 1.538.179 1.195.447 1.154.770 1.405.390 1.416.853 1.638.499
Gross Profit/Loss - EUR 14.932 49.273 295.458 358.258 531.281 611.454 498.859 1.051.660 669.255 498.777
Net Profit/Loss - EUR 14.932 47.777 241.794 297.752 441.587 527.210 413.129 895.573 568.494 416.635
Employees 8 14 17 16 19 19 17 15 15 15
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 2.1%, from 2.078.376 euro in the year 2023, to 2.110.322 euro in 2024. The Net Profit decreased by -148.682 euro, from 568.494 euro in 2023, to 416.635 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmalink Srl

Rating financiar

Financial Rating -
PHARMALINK SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmalink Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmalink Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmalink Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmalink Srl - CUI 31646819

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 4.347 2.146 69.925 63.736 161.716 91.185 46.357 48.034 46.389 83.066
Current Assets 251.711 268.571 443.654 525.086 871.842 717.424 605.910 1.794.904 782.794 936.409
Inventories 35.018 26.302 32.014 56.505 30.029 38.835 28.487 41.742 174.239 251.491
Receivables 207.390 188.070 409.531 464.536 730.420 617.298 443.041 1.565.888 586.582 651.730
Cash 9.304 54.199 2.109 4.045 111.393 61.291 134.381 187.274 21.974 33.188
Shareholders Funds -75.363 -541 241.261 341.074 630.063 568.888 453.882 936.453 609.250 457.163
Social Capital 11.249 37.410 36.777 36.102 35.403 34.732 33.961 34.067 33.963 33.774
Debts 331.553 271.693 280.446 255.079 414.235 248.951 206.463 916.222 201.322 549.838
Income in Advance 0 0 0 0 0 0 0 0 26.526 26.407
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7020 - 7020"
CAEN Financial Year 7022
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 936.409 euro in 2024 which includes Inventories of 251.491 euro, Receivables of 651.730 euro and cash availability of 33.188 euro.
The company's Equity was valued at 457.163 euro, while total Liabilities amounted to 549.838 euro. Equity decreased by -148.682 euro, from 609.250 euro in 2023, to 457.163 in 2024. The Debt Ratio was 53.2% in the year 2024.

Risk Reports Prices

Reviews - Pharmalink Srl

Comments - Pharmalink Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.